EMBECTA CORP. Earnings Per Share (Diluted)
EMBECTA CORP. (EMBC) reported Earnings Per Share (Diluted) of $0.36 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-07
- EMBECTA CORP. earnings per share, diluted for the quarter ending 2026-06-30 was $0.36, a 53.85% decline year-over-year.
- EMBECTA CORP. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.07, a 117.50% decline year-over-year.
- EMBECTA CORP. earnings per share, diluted for the quarter ending 2025-12-31 was $0.74.
- EMBECTA CORP. earnings per share, diluted for the quarter ending 2025-09-30 was $0.44, a 78.93% increase year-over-year.
- EMBECTA CORP. earnings per share, diluted for fiscal 2025 was $1.62, a 20.90% increase from fiscal 2024.
- EMBECTA CORP. earnings per share, diluted for fiscal 2024 was $1.34, a 9.84% increase from fiscal 2023.
- EMBECTA CORP. earnings per share, diluted for fiscal 2023 was $1.22, a 68.64% decline from fiscal 2022.
- EMBECTA CORP. earnings per share, diluted for fiscal 2022 was $3.89, a 46.57% decline from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.36 10-Q · filed 2026-08-07 | $0.29 derived: net income ÷ weighted average shares · filed 2026-08-07 | $1.03 10-Q · filed 2026-08-07 | $1.48 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2026-03-31 | -$0.07 10-Q · filed 2026-05-05 | $0.67 10-Q · filed 2026-05-05 | $1.12 derived: net income ÷ weighted average shares · filed 2026-05-05 | $1.89 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-12-31 | $0.74 10-Q · filed 2026-02-05 | $1.19 derived: net income ÷ weighted average shares · filed 2026-02-05 | $1.96 derived: net income ÷ weighted average shares · filed 2026-08-07 | $2.37 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-09-30 | $0.44 derived: net income ÷ weighted average shares · filed 2025-11-25 | $1.22 derived: net income ÷ weighted average shares · filed 2026-08-07 | $1.62 derived: net income ÷ weighted average shares · filed 2026-08-07 | $1.62 10-K · filed 2025-11-25 |
| 2025-06-30 | $0.78 10-Q · filed 2026-08-07 | $1.18 derived: net income ÷ weighted average shares · filed 2026-08-07 | $1.18 10-Q · filed 2026-08-07 | $1.43 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-03-31 | $0.40 10-Q · filed 2026-05-05 | $0.40 10-Q · filed 2026-05-05 | $0.65 derived: net income ÷ weighted average shares · filed 2026-05-05 | $0.90 derived: net income ÷ weighted average shares · filed 2026-05-05 |
| 2024-12-31 | $0.00 10-Q · filed 2026-02-05 | $0.25 derived: net income ÷ weighted average shares · filed 2026-02-05 | $0.50 derived: net income ÷ weighted average shares · filed 2026-02-05 | $1.00 derived: net income ÷ weighted average shares · filed 2026-02-05 |
| 2024-09-30 | $0.25 derived: net income ÷ weighted average shares · filed 2025-11-25 | $0.50 derived: net income ÷ weighted average shares · filed 2025-11-25 | $1.00 derived: net income ÷ weighted average shares · filed 2025-11-25 | $1.34 10-K · filed 2025-11-25 |
| 2024-06-30 | $0.25 10-Q · filed 2025-08-08 | $0.75 derived: net income ÷ weighted average shares · filed 2025-08-08 | $1.10 10-Q · filed 2025-08-08 | $1.21 derived: net income ÷ weighted average shares · filed 2025-11-25 |
| 2024-03-31 | $0.50 10-Q · filed 2025-05-09 | $0.85 10-Q · filed 2025-05-09 | $0.95 derived: net income ÷ weighted average shares · filed 2025-11-25 | $1.22 derived: net income ÷ weighted average shares · filed 2025-11-25 |
| 2023-12-31 | $0.35 10-Q · filed 2025-02-06 | $0.45 derived: net income ÷ weighted average shares · filed 2025-11-25 | $0.72 derived: net income ÷ weighted average shares · filed 2025-11-25 | $0.96 derived: net income ÷ weighted average shares · filed 2025-11-25 |
| 2023-09-30 | $0.10 derived: net income ÷ weighted average shares · filed 2025-11-25 | $0.37 derived: net income ÷ weighted average shares · filed 2025-11-25 | $0.61 derived: net income ÷ weighted average shares · filed 2025-11-25 | $1.22 10-K · filed 2025-11-25 |
| 2023-06-30 | $0.26 10-Q · filed 2024-08-09 | $0.51 derived: net income ÷ weighted average shares · filed 2024-08-09 | $1.12 10-Q · filed 2024-08-09 | $0.83 derived: net income ÷ weighted average shares · filed 2024-12-11 |
| 2023-03-31 | $0.24 10-Q · filed 2024-05-09 | $0.85 10-Q · filed 2024-05-09 | $0.56 derived: net income ÷ weighted average shares · filed 2024-12-11 | $1.65 derived: net income ÷ weighted average shares · filed 2024-12-11 |
| 2022-12-31 | $0.61 10-Q · filed 2024-02-09 | $0.32 derived: net income ÷ weighted average shares · filed 2024-12-11 | $1.41 derived: net income ÷ weighted average shares · filed 2024-12-11 | $2.80 derived: net income ÷ weighted average shares · filed 2024-12-11 |
| 2022-09-30 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-12-11 | $0.80 derived: net income ÷ weighted average shares · filed 2024-12-11 | $2.19 derived: net income ÷ weighted average shares · filed 2024-12-11 | $3.89 10-K · filed 2024-12-11 |
| 2022-06-30 | $1.07 10-Q · filed 2023-08-08 | $2.45 derived: net income ÷ weighted average shares · filed 2023-08-08 | $4.14 10-Q · filed 2023-08-08 | $5.93 derived: net income ÷ weighted average shares · filed 2023-11-29 |
| 2022-03-31 | $1.38 10-Q · filed 2023-05-12 | $3.09 10-Q · filed 2023-05-12 | $4.87 derived: net income ÷ weighted average shares · filed 2023-11-29 | $6.69 derived: net income ÷ weighted average shares · filed 2023-11-29 |
| 2021-12-31 | $1.73 10-Q · filed 2023-02-14 | $3.50 derived: net income ÷ weighted average shares · filed 2023-11-29 | $5.32 derived: net income ÷ weighted average shares · filed 2023-11-29 | $7.19 derived: net income ÷ weighted average shares · filed 2023-11-29 |
| 2021-09-30 | $1.77 derived: net income ÷ weighted average shares · filed 2023-11-29 | $3.59 derived: net income ÷ weighted average shares · filed 2023-11-29 | $5.45 derived: net income ÷ weighted average shares · filed 2023-11-29 | $7.28 10-K · filed 2023-11-29 |
| 2021-06-30 | $1.81 10-Q · filed 2022-08-15 | $3.68 derived: net income ÷ weighted average shares · filed 2022-08-15 | $5.50 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $1.87 10-Q · filed 2022-05-13 | $3.69 10-Q · filed 2022-05-13 | ||
| 2020-09-30 | $7.50 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |